Vasopressin and oxytocin are nonapeptides that are present in all placental mammals. Although similar in structure, they serve different functions (Ramsay, 1983) . Vasopressin has anti-diuretic activities and is involved in hydromineral regulation, whereas oxytocin has uterotonic and milk-ejection activities and regulates aspects of reproductive behavior. Peptides related to both vasopressin and oxytocin are present in all vertebrate classes, except the cyclostomes, which have only the vasopressin-related peptide vasotocin (reviewed by Acher, 1993) . Peptides of the vasopressin family have a basic amino acid residue at position 8 in common, whereas oxytocin and related peptides have a neutral amino acid residue at this position. The chemical nature of this amino acid residue is thought to be of critical importance in the interactions of the peptides with their respective receptors.
The structure of the protein precursors of the vasopressin/ oxytocin superfamily are very similar, with a signal peptide domain followed by the nonapeptide, neurophysin, and copeptin domains (reviewed by Acher, 1993) , although the copeptin domain is lacking in the oxytocin and mesotocin precursors. The precursor proteins are encoded by different genes that have an identical exon-intron organization in mammals Ivell and Richter, 1984; Ruppert et al., 1984; Sausville et al., 1985; Hara et al., 1990) , bony fish (Morley et al., I990) , and cyclostomes (Heierhorst et al., 1992) . Together with the phylogenetic distribution of the peptides, these data suggest that the superfamily evolved from an ancestral gene by the mechanism of gene duplication.
Because lampreys and hagfish have only vasotocin (Lane et al., 1988; Heierhorst et al., 1992) , it has been hypothesized that the vasotocin gene is the present-day representative of the ancestral gene, and that the gene duplication occurred between the radiation of cyclostomes and cartilaginous fish, about 450 million years ago (Acher, 1980) .
Vasopressin-related peptides are not restricted to the vertebrates, but have been identified in several invertebrate phyla as well, including insects (Proux et al., 1987) , molluscs (Cruz et al., 1987; McMaster et al., 1992) and annelids (Salzet et al., 1993) . Oxytocin-related peptides have similarly been found in molluscs (Reich, 1992) and annelids (Oumi et al., 1994) . The presence of both vasopressin-and oxytocin-related peptides in invertebrates leads to an alternative hypothesis stating that duplication of the ancestral gene occurred prior to the divergence of vertebrates and invertebrates, over 600 million years ago (Van Kesteren et al., 1992) . However, this hypothesis has not been verified by experimental data showing co-occurrence of vasopressin-and oxytocin-related peptides in a single invertebrate species, or by demonstrating functional divergence of the two types of peptide in invertebrates. Thus, species variation instead of gene duplication may explain the appearance of either vasopressin-or oxytocin-related peptides in invertebrates. In this article, we attempt to distinguish between these possibilities by studying vasopressin-and oxytocin-related peptides in the mollusc Lymnuea stugnalis. Previous cDNA cloning studies (Van Kesteren et al., 1992) have identified a vasopressin-like precursor, pro-Lys-conopressin,
in Lymnaea. To demonstrate that conopressin has the typical tertiary structure of vasopressin-related peptides and is transported to peripheral target tissues, we have now identified Lys-conopressin from both the CNS and the male copulatory organs. At the same time, we show evidence for the absence of an oxytocin-related peptide or cDNA. Moreover, genomic analysis strongly suggests that the conopressin gene is a single copy gene in Lymnuea, and that related genes are absent. Although structurally related to vasopressin, conopressin has functions in the control of sexual behavior that in mammals usually are associated with oxytocin. The implications of these findings for theories of the molecular and functional evolution of the vasopressin/oxytocin superfamily are discussed.
Materials and Methods
Animals, peptides, and antibodies. Adult specimens of L. stugnalis (shell height 28-34 mm), bred in the laboratory under standard conditions, were used. Synthetic Lys-conopressin G was obtained from Bachem Feinchemikalien AG (Budendorf, Switzerland).
[Ilex]-conopressin (Cys-Phe-Be-Arg-Asn-Cys-Pro-Be-Gly-amide) was synthesized using a peptide synthesizer from Applied Biosystems (Foster City, CA). After formation of the intramolecular disulphide bridge, the final structure and purity of the peptide was confirmed by mass spectrometry and amino acid sequencing. Antiserum WlE was a gift of Dr. J. P H. Burbach (Rudolf Magnus Institute, Utrecht, The Netherlands) and recognizes the carboxy-terminal sequence of Arg-vasopressin (Liu and Burbach, 1987) , and antiserum 121 was a gift of Dr. E W. Van Leeuwen (Netherlands Institute for Brain Research, Amsterdam, The Netherlands) and recognizes the carboxy-terminal sequence of Lys-vasopressin (Swaab and Pool, 1975 ). An anti-CDCH antiserum was used as described (Van Minnen et al., 1989) . A synthetic peptide fragment corresponding to the 11 amino-terminal amino acids (SLDTGMVTSRE) of Lymnaeu neurophysin was a gift of Dr. R. H. M. Ebberink (Applied Biosystems, Maarssen, The Netherlands). An antiserum to the fragment was raised in mice as described (Van Minnen and Schallig, 1990) .
Purijicution of conopressin. Relevant tissues (CNS, or vas deferens and penis complex together) of 1000 snails were homogenized in 0.1 M acetic acid and centrifuged. The supernatant was applied to Supelclean C-8 cartridges (Supelco Inc., Bellefonte, USA) previously activated with methanol and solvent A (7.5 mM trifluoroacetic acid). After loading, cartridges were washed with 4 ml solvent A, and peptides were eluted with 2 ml solvent B (7.0 mM trifluoroacetic acid in 60% acetonitrile). The effluents were lyophilized and redissolved in bidistilled water. High-performance gel permeation chromatography (HPGPC) and reverse-phase high-performance liquid chromatography (rpHPLC) were performed using an M-720 system controller, an M-730 data module, an M-600 solvent delivery system, and an M-441 UV/VB absorbance detector (Waters Assoc., Bedford, MA). The flow rate was 1 mllmin, and fractions of 1 ml were collected.
The peptide extract was applied to tandemly arranged Protein-Pak I-125 and I-300 gel permeation columns (Waters Assoc.) in several successive runs. The running solvent consisted of 30% acetonitrile in 7.5 mM TFA. Fractions containing the small peptides were pooled, lyophilized, redissolved in bidistilled water, and applied to a Nucleosil 300 C-18 column (5 pm, 4.6 X 250 mm), equilibrated with solvent A, in several successive runs. Elution was achieved by a linear gradient of O-10% solvent B in 5 min, lo-35% solvent B in 35 min, and 35-100% solvent B in 25 min. Fractions were lyophilized, redissolved in bidistilled water, and tested in a dotting immunoassay (DIA) according to Li et al. (1989) . In short, 1% of each fraction was dot blotted on nitrocellulose paper, heat fixed at 106°C for 1.5 min, and then stained with antisera W 1 E and 121. Corresponding immunoreactive fractions were pooled and applied to a Nucleosil 120 C-l 8 column (3 urn, 4.6 X 150 mm) equilibrated with solvent A. Elution was achieved by a linear gradient of 20-35% solvent B in 60 min. Fractions were Ivoohilized.
d I redissolved in bidistilled water, and screened in the DIA. The immunoreactive fraction was applied to the same C-18 column equilibrated with 25 mM NH,Ac for the CNS material. Elution was achieved by a linear gradient of IO-40% of 25 mM NH,Ac in 60% acetonitrile in 60 min. The vas deferens and penis complex material was applied to the same column equilibrated with 0.05% HCl, and elution was achieved by applying 0.05% HCl/60% acetonitrile in a linear gradient of O-5% in 5 min. and 5-35% in 60 min. FmCtiOnS were lvoohilized. redissolved in bidistilled water, and screened using the DIA: L Sequencing, co-elution, and muss determination. The immunoreactive fraction of the final HPLC step was subjected to automated Edman degradation using a model 473A pulse liquid protein sequencer (Applied Biosystems). To verify the sequence and complete the structural characterization, synthetic Lys-conopressin was used in co-elution experiments employing the same HPLC system, solvents, and gradients as in the first and the third rpHPLC step described above. In addition, the purification procedure was repeated as described above, and the immunoreactive fraction of the final HPLC step was subjected to mass spectrometry using a Bio-ion 20/30 plasma desorption mass spectrometer (Applied Biosystems).
Anti-oxytocin radioimmunoussuy. CNS of 200 snails were homogenized, prepurified, and subjected to HPGPC as described above. All fractions were lyophilized, redissolved in bidistilled water, and tested in an anti-oxytocin radioimmunoassay as described (Reich, 1992) .
Polymerase chain reaction (PCR) umplijicution of putative oxytocin encoding cDNAs. Two degenerate oligonucleotides, OTI and OT2, were synthesized, based on the putative oxytocin-like sequences Cys-(Phe/ Tyr)-(Phe/Ile)-Arg-Asn-Cys-Pro-(Leu/Ile/Val)-Gly and the following amidation and processing sequence Gly-Lys-Arg [OTl : 5'.GGAAGC-
Both oligonucleotides were provided with Hind III restriction site extensions on the 5' ends and used as primers in a PCR as described (Van Kesteren et al., 1992) . In short, cDNA was isolated from a XgtlO cDNA library of the CNS (Vreugdenhil et al., 1988 ) and used as a template. As reverse primer, a h primer was used, which is complementary to a sequence in the left arm of XgtlO (X primer: S'-AGCAAGTTCAGCCTGGTT-AAGTCC-3'). In the first PCR, cDNA was amplified between OTl and the X primer, using 40 cycles: 94°C for 1 min, 52°C for 1 min, and 72°C for 2 min. After amplification, 5 pl of the PCR mixture were reamplified under the same conditions, now using OT2 and the h primer. Amplified cDNA was digested with Eco RI and Hind III, cloned into Ml3mp18 and sequenced using the dideoxy chain termination method (Sanger et al., 1977) .
Low stringency screening of Lymnaea cDNA and genomic libraries for conopressin-related sequences. From an amplified cDNA library of Lymnaea CNS in hgtl0 (for details, see Vreugdenhil et al., 1988) , as well as from an amplified Lyymnaea genomic library in EMBL3 (for details, see Bogerd et al., 1993) , recombinant phages (3.0 X IO5 and 1.2 X IO', respectively) were plated on 245 X 245 mm dishes (0.6 X lo5 phages/dish) and absorbed to replica Hybond N' filters (Amersham Int., Amersham, UK). After prehybridization for 16 hr, the filters were hybridized at 55°C for 60 hr to a i2P-labeled probe that was generated by primer extension on a single stranded Ml3 clone containing the full length conopressin cDNA. The hybridization solution contained 6X SSC (1X SSC = 150 mM NaCl, 15 mM sodium citrate; pH 7.4), 5X Denhardt's (according to Maniatis et al., 1982) , 0.1% SDS and 10 kg/ ml salmon sperm DNA. The specific activity of the probe was > 3X lo8 dpm/pg. Filters were washed in 2X SSC/O.l% SDS at 55°C for 30 min and autoradiographed. Positive clones were replated at lower plaque density and screened with the cDNA probe. Genomic clones were also screened with synthetic oligonucleotides specific for either the leader sequence or the neurophysin domain of the conopressin gene. Inserts from positive cDNA clones were subcloned and sequenced. Of three positive genomic clones, XDNA was mapped for restriction endonuclease sites for the enzymes Bgl II, Eco RI, Hind III, Pst I, Sal I, and Xba I by partial digestion and hybridization to an oligonucleotide directed to the right arm of EMBL3. The clones were directly sequenced amplification of the XDNA using 5'.end labeled conopressin specific primers and dideoxy chain termination mixtures (Lasham and Darlison, 1993) .
Genomic Southern anulysis. Genomic DNA was isolated from 100 CNS using the G-nome DNA Kit (Bio 101, La Jolla, CA), and digested with 200 units of either of the restriction enzymes Bgl II, Eco RI, Hind III, Pst I, and Xha I (8 yg DNA/digestion). The digested DNA was electrophoresed on a 0.8% agarose gel and transblotted to Hybond N+ filter. After prehybridization, the filter was hybridized for 60 hr to a ??Plabeled PCR fragment containing the entire coding sequence of the conopressin cDNA (specific activity: > 5X lox dpm/p,g). Hybridization conditions were as described above. The filter was washed in I X SSC at 55°C for 30 min and autoradiographed for 20 hr. Thereafter, the filter was washed in 0.2X SSC at 65°C for 30 min and autoradiographed for 7 d.
Immunoc)ltnchemistry and in situ hybridization. CNS and vas deferens were dissected and fixed in a mixture of 1% paraformaldehyde and 1% acetic acid or in Bouin's fixative. Tissues were dehydrated, embedded in paraffin, cut to 7 pm sections, and alternately mounted on 0.5% gelatine/0.5% chrome-alum coated microscope slides. For immunocytochemistry, dewaxed slides were incubated at 4°C for 16-18 hr with primary antibodies diluted in Tris-buffered saline (TBS; 50 mM Tris, 150 mM NaC1; pH 7.4) containing 0.25% gelatine and 5% Triton X-100 (TBS.GT). Anti-neurophysin was diluted 1:200 and anti-Caudodorsal Cell Hormone (anti-CDCH) 1:500. After two IO min rinses in TBS-GT, sections were incubated at 20°C for 1 hr with a secondary antibody coupled to horseradish peroxidase, diluted I : 100 in TBS. After rinsing in TBS-GT, horseradish peroxidase was visualized by incubation in 0.05% 3,3 diaminobenLidine tetrahydrochloride and 0.01% H,O, in TBS.
In situ hybridization procedures (pretreatment, labeling, hybridiza- Figure   1 . Purification of conopressin from the CNS of Lymnaeu. A, Chromatogram of the first rpHPLC step, representing one-third of the total CNS material (330 animal equivalents). Synthetic Lys-conopressin co-eluted with fraction 39. B, Chromatogram of the final rpHPLC step, representing the tofdl CNS material (1000 animal equivalents). Synthetic Lys-conopressin coeluted with fraction 48, which was also used for molecular characterization. Immunoreactive fractions are indicated by black squares at the time axis. tion) were carried out as described (De Lange et al., 1994 (Li et al., 1992) in a 1 ml chamber tilled with snail Ringer (Geraerts et al., 1984) . Peptides were added at different concentrations under continuous superfusion with Ringer at a flow rate of 1 ml/min and contractions were displayed on a recorder. Dose-response curves were constructed by plotting the contraction frequencies (mean of four experiments) semilogarithmically versus the concentration of the peptide. Membrane potential ejj%cts of conopressin on caudodorsal cells.
Electrophysiological recordings were performed on Caudodorsal cells (CDC) in situ in the isolated CNS (Kits et al., 199 I) . Membrane potential recordings were made using microelectrodes (Clark, Reading, UK) filled with 0.1 M KCI and with resistances of 15-30 Ma connected to high input resistance amplifiers built in the laboratory. Recordings were plotted on paper with a Gould 2200 pen recorder. Bath saline had the following composition: 30 mM NaCI, IO mM NaCH,SO,, 5 mM Na-HCO,, 1.7 mM KCl, 4 mM CaCI,, 1.5 mM MgCl,, 10 mM Hepes; pH 7.8.
Results
Purijcation and structural identi$cation qf Lymnaea conopressin After the first rpHPLC step, two separate immunoreactive fractions (fractions 28 and 39; Fig. IA ) could be detected in CNS material with the antisera WlE and 121. Fraction 39 was further purified, and after a third rpHPLC step, two immunoreactive fractions (47 and 48; Fig. 1B ) could be detected. The peptide material in fraction 48 was sequenced without modification of cysteine residues (Table 1 ). In the first and the sixth cycle of the Edman degradation, no PTH-amino acids could be detected. Assuming that the peptide contains cysteine residues at the corresponding positions, its amino acid sequence [(Cys)-Phe-Ile-ArgAsn-(Cys)-Pro-Lys-Gly] is identical to the primary sequence of Lys-conopressin (Cruz et al., 1987) . Plasma desorption mass spectrometry indicated that the peptide has an MH' of 1036.7 Da. HPLC analysis demonstrated co-elution of synthetic Lysconopressin with the native peptide in two rpHPLC systems (7.5 mM TFA and 25 mM NH,Ac).
Further purification and characterization of the immunoreactive substance of fraction 28 (Fig. 1A) revealed a novel peptide with the amino acid sequence Leu-Ala-Ser-Leu-Gly-Gly-Lys-
Ser-Ser-Ser-Arg-Pro-Ala-Pro-Arg-Gly-amide. The structure of this peptide was confirmed by mass spectrometry and co-elution with a synthetic form of the peptide. The carboxy-terminal sequence Pro-Arg-Gly-NH, explains its immunoreactivity to the anti-vasopressin antisera. However, because it lacks the structural characteristics of the vasopressin/oxytocin superfamily (e.g., the presence of cysteine residues that can form a disulphide bridge), it is not further considered here.
Lys-conopressin could also be purified from the vas deferens and the penis complex together (data not shown). Its identity was established by amino acid sequencing and co-elution with synthetic Lys-conopressin.
Anti-oxytocin radioimmunoassay
A peptide extract of 200 Lymnaea CNS was size fractionated on HPGPC and all fractions were tested in a radioimmunoassay with 1251-oxytocin as the tracer (Reich, 1992) . No immunoreactivity significantly above background could be detected in these fractions (data not shown).
PCR amplijcation qf putative oxytocin encoding cDNAs Amplification of AgtlO cDNA using primer OT I in combination with the A primer yielded many DNA fragments when analized by electrophoresis on an agarose gel. Reamplification of the PCR mixture using primer OT2 in combination with the A primer yielded a single DNA fragment of 700 base pairs (data not shown). This fragment was cloned, and 30 clones were sequenced and shown to contain the conopressin cDNA. To exclude the possibility that the amplification product consisted of the conopressin cDNA and a less abundant fragment representing a related cDNA species, -300 additional clones were hybridized to an oligonucleotide specific for the 3' trailer sequence of the conopressin cDNA. No clones were found that did not hybridize, demonstrating that the amplification product most likely consisted of only the conopressin cDNA.
Low-stringency screening cf Lymnaea cDNA and genomic libraries ,fiw conopressin-related sequences Low-stringency hybridization of a cDNA library of Lymnaea CNS yielded 26 positive clones. After subcloning and sequence analysis, two of these appeared to contain the conopressin cDNA sequence. All others contained sequences that were not related to conopressin, and were apparently isolated because of short stretches of DNA showing slight homology with the conopressin cDNA sequence (data not shown).
Low-stringency hybridization (i.e., washing conditions: 2X SSC/O.l% SDS at 55°C) of a Lymnaea genomic library yielded 17 clones that after two rounds of screening still hybridized to the conopressin cDNA probe. Of these clones, 10 hybridized to an oligonucleotide specific for the leader sequence of the conopressin cDNA, and 7 to an oligonucleotide specific for the neurophysin domain. There was no overlap in these two groups of clones. One clone (hCP56) of the first group and two (ACP21 and XCP3 1) of the second were used for restriction enzyme mapping and sequence analysis. The restriction map of hCP56 shows no overlap with those of XCP21 and ACP3 1, while the latter two have a large part in common. Within the overlapping part, however, ACP21 contains two Xba I sites that are absent in ACP3 1, whereas ACP31 contains two Xba I sites and one Pst I site that are absent in ACP21 (Fig. 2A) . Sequencing of the three clones revealed that the conopressin gene is composed of three exons interrupted by two introns at exactly the same locations as in the vasopressin and oxytocin genes of vertebrates (Fig. 2B) . Exon I and the 5' part of intron 1 are located on ACP56 and the 3' part of intron 1 and the rest of the gene are located on both ACP21 and ACP31 (Fig. 2) . The exon sequences of ACP56 and ACP21 are identical to the conopressin cDNA sequence (Van Kesteren et al., 1992) . Clone ACP31, however, has two conservative third-base substitutions in the neurophysin encoding part of the gene (one in exon II and one in exon III) and numerous substitutions in the 3' noncoding sequence and in the introns, as well as an 18 base pair insertion in intron 2 (Fig. 2B) . In exon III, at 14 nucleotides after the first putative poly7 adenylation signal (at nucleotide 1245 of the 2.5 kb cDNA; Van Kesteren et al., 1992) , sequence identity between gene and cDNA ends. Since many additional cDNA clones have been sequenced, all containing poly(A)-tails at position 1245 (data not shown), we suggest that the rest of the cDNA is not a part of the conopressin gene and became unspecifically ligated to the conopressin cDNA during construction of the library.
Genomic Southern analysis
Southern blots containing genomic DNA digested with five different restriction enzymes did not show different hybridization patterns when hybridized to a PCR fragment of the coding region of the conopressin cDNA at low (1 X SSC, 55°C) or at high (0.2X SSC, 65°C) stringency (Fig. 3) . In each lane, three to six bands hybridized at low stringency and could not be washed off at high stringency. Only in the lanes containing Bgl II and Pst I digested DNA, a few faint bands were present that disappeared after high-stringency washing.
Localization of conopressin and conopressin transcripts
To determine the site of synthesis of conopressin, anti-neurophysin antiserum and conopressin-specific oligonucleotides were applied to alternate sections of the CNS. Both the antiserum and the oligonucleotide probe recognized one neuron at the caudal surface of each pedal ganglion (not shown) and neurons of the anterior lobes of both cerebral ganglia (Fig. 4A,B) . The antineurophysin antiserum stained also axon bundles in the penis nerve (Fig. 4C ) and along the vas deferens (Fig. 40) . Positive staining was also observed in axons in the cerebral ganglia located in close proximity of the CDC (Fig. 4E) . When the alternate sections were stained with anti-CDCH, to visualize the axons of the CDC, anti-neurophysin positive axons and anti-CDCH positive axons could be observed within the cerebral ganglia in close proximity of each other (Fig. 4E,F) .
l?jfects of Lys-conopressin and [IleX]-conopressin on the vas deferens
Application of Lys-conopressin or [Ile8]-conopressin to the dissected anterior vas deferens (the part of the vas deferens that runs from the body wall to the penis; Barraud, 1957) elicited contractions that increased with frequency in a dose-dependent manner. The contraction frequency during the first minute following application (mean of four experiments) was used to construct dose-response curves (Fig. 5A) 
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CTG CTG *cc GCC GCT GTC cl% *CA cm TCA CTG ACG GAC GCT TGT TTC ATC *Go MC TGT cc* lvvL GGT GGA AAG cG* TCG **a GAC ACG GGC ATG GTG *co Leu Leu Thr Ala Ala Val Leu Se= LBU Se= Leu Thr ASP Ala Cye Phe Ile A=g &sn Cys PEO lye Gly Gly Lys ?,=g Se= LB,, Asp Th= Gly jet "al Thr --,intron 1 hCP21 lyjC ATG AA0 TGT GGG CCA GGT GGC ACC DDA CA0 TOT OTC! GGA CC0 AGC ATC TGC TGT GGT CA0 GAC TTT GGC TGT CAT GTC GGG ACA GCG GAG GCG GCG GT,,
. . '&S Met W'S Q'S Gly Pro Gly Gly Th= Gly Gln Cya Val Gly P=o Se= Ile WS CYS Gly Gin ASP Phe Gly Cys His Val Gly Thr Ala Glu Ala Ala val kPil1
WC CM CAD GAG AAC GAC AGC TCG ACC CC0 TOC CT0 OTC ZAG GGG GAG GCG TGT GGG TCA ADO OAT GCG GGC AAC TGT GTG GCA GAC GGC ATA TGC TGT GA* ,J&.p31 ~.. suggesting that Lys-conopressin and [Ile8]-conopressin interact with the same receptor.
of action potential frequency was observed over the same time period (see also Kits, 1980) .
Mernbmne potentiul effects of conopressirl on CDC
Discussion
Electrical stimulation of CDC in situ in the isolated CNS evoked an afterdischarge that lasted -50 min. Bath application of conopressin resulted in a hyperpolarization of the membrane potential and an inhibition of electrical activity (Fig. 6) . Due to the hyperpolarization, an increase in the spike amplitude occurred. To quantify the effect of conopressin, action potential frequencies were measured during 40 set before and 40 set after application of the peptide. Before application, a frequency of 0.7 + 0.2 spikeslsec was observed, whereas afterwards the frequency was 0.4 -C 0.1 spikes/set (mean ?Z SD; n = 4). Thus, conopressin significantly reduced the action potential frequency of the discharge (p < 0.02) whereas in control discharges, no reduction A single copy conopressin gene is the 0111, member of the vusopressin/oxytocin gene funiil~ present in Lymnaea We used several independent methods to examine the presence of vasopressin-and oxytocin-related peptides and corresponding genes in Lymnnen: peptide purification and characterization, PCR-amplification, and low-stringency hybridization of cDNA and genomic DNA. Two antisera (W IE and 121) that specifically recognize the Pro-Lys/Arg-Gly-amide carboxy-terminal sequence typical of vasopressin and vasopressin-related peptides (Swaab and Pool, 1975; Liu and Burbach, 1987) were employed to detect vasopressin-related peptides in extracts of the brain. One of the two immunoreactive peptides that were identified Figure 3 . Genomic Southern blot analysis of the Lymnaea conopressin gene. A blot containing Lymnaea genomic DNA digested with BgZ II, Eco RI, Hind III, Pst I, and Xba I was hybridized at 55°C with a probe corresponding to the entire coding region of the conopressin cDNA, and washed at low stringency (1 X SSC/O.l% SDS, 55°C; left panel) and thereafter at high stringency (0.2X SSC/O.l% SDS, 65°C; right panel). No differences were observed between the hybridization patterns at these two washing conditions, except for some faint bands in the Bgl II and the Pst I lanes, which disappeared after high-stringency washing. Size markers are indicated between the two panels. lx SSC; 0.1% SDS 55 "C from the brain has a primary structure identical to that of Lysconopressin, originally identified in C. geographus (Cruz et al., 1987) , except that the cysteine residues at positions 1 and 6 and the carboxy-terminal amide could not be determined directly. However, because the MH+ of the native peptide (1036.7 Da) corresponds with the expected MH+ of Lys-conopressin (1034.3 Da) and as it co-elutes with synthetic Lys-conopressin in two rpHPLC systems, it must have a disulphide bridge involving cysteine residues at positions 1 and 6, as well as an amidated carboxy-terminal glycine residue. Thus, Lymnaea conopressin is identical with Lys-conopressin and has the structural characteristics typical for vasopressin and related peptides, including the basic amino acid residue at position 8.
To investigate the presence of oxytocin or oxytocin-related peptides in the Lymnaea CNS, we used a radioimmunoassay employing an antiserum that was raised against oxytocin. In displacement studies, this antiserum recognized the oxytocin-related peptides isotocin, mesotocin, and cephalotocin, but not vasopressin or vasotocin (G. Reich, personal communication) . No immunoreactive peptides were found in HPGPC fractions of the Lymnaea CNS. However, the antiserum may not recognize all oxytocin-related peptides, and the absence of a peptide related to oxytocin in Lymnaea cannot be concluded on these grounds alone. Therefore, we examined the possibility that multiple members of the vasopressin/oxytocin gene family exist in Lym--21kb --9.4 kb --6.6 kb --5.0 kb --4.3 kb --3.5 kb --2.3 kb --2.0 kb --1.6kb --1.3 kb --l.Okb -0.2x SSC; 0.1% SDS 65 "C naea. In mammals, the vasopressin and oxytocin genes consist of three exons, with a remarkably high-sequence identity between the second exon of each gene that is maintained by the mechanism of gene conversion (Ruppert et al., 1984) . Consequently, vasopressin and oxytocin genes cross-hybridize, even under high stringency conditions (see for instance, Land et al., 1983) . Members of multigene families are commonly identified by low-stringency hybridization using one of the genes as a probe (see for instance, Haeflinger et al., 1992; Garcia et al., 1995) . Therefore, we applied low-stringency hybridization with conopressin cDNA to identify putative oxytocin-like cDNAs and genes in Lymnaea. In our experiments, hybridization conditions were chosen such that even sequences with only 50% sequence identity would have been detected (see Maniatis et al., 1982) . A further lowering of the stringency resulted in a strong increase of background hybridization on genomic Southern blots, whereas no additional bands appeared (data not shown). We first screened a cDNA library of Lymnaea CNS under low-stringency conditions in order to find conopressin-related cDNAs. In addition to two conopressin clones, 24 positive clones were isolated; however, none of these clones encoded a conopressinrelated peptide precursor. Moreover, amplification of putative oxytocin-like sequences from the same cDNA library using a PCR approach that was previously used to isolate the conopressin cDNA did not result in the isolation of oxytocin-like cDNAs.
Because both the screening and the PCR approach are restricted to genes that are expressed in the CNS, we also performed a screening of a genomic DNA library under low-stringency conditions. This resulted in the isolation of 17 clones that hybridized to the conopressin cDNA. All clones contain parts of the conopressin gene, as was verified by hybridization under high-stringency conditions to oligonucleotides specific for the leader sequence and the neurophysin domain of the conopressin cDNA, and by sequencing of the part encoding conopressin of all 10 clones that contain exon I. Together, these data show that an oxytocin-related peptide or gene can not be identified in Lymnaea using various well-established peptide chemical and molecular biological methods, and strongly suggest that conopressin is the only member of the vasopressin/oxytocin superfamily in Lymnaea.
Restriction enzyme mapping and nucleotide sequencing revealed that the conopressin gene is split by two introns at exactly the same position as in the vasopressin and oxytocin genes (Fig.  2) . Thus, the exon-intron organization of the members of vasopressinloxytocin gene family has been conserved during at least 600 million years of evolution. Differences in the restriction maps and nucleotide sequences of clones XCP21 and ACP31 (Fig. 2) are very likely due to polymorphism, as the two clones do not encode different peptide precursors and the differences are almost exclusively restricted to the noncoding parts of the gene. To verify this, we performed genomic Southern blot hybridizations (Fig. 3) . The conopressin cDNA probe identified multiple bands in each restriction enzyme digestion of genomic DNA when hybridized under low-stringency conditions (1 X SSC at 55°C). After washing the blot at high stringency (0.2X SSC at 65"(Z), all bands remained equally intens, except for some faint bands in the Bgl II and the Pst I lanes, which disappeared. Since this was not observed in any of the other digestions, these bands are most likely due to aspecific hybridization under low stringency conditions. The Xba I lane (Fig. 3) showed that the two fragments (1.2 kb and 4.5 kb) containing exon II in clones XCP21 and XCP31 hybridized with different intensities, suggesting that they have an unequal distribution in the snail population and represent polymorphisms. Hybridization of the blot with exon-specific probes (not shown) revealed similar restriction site polymorphisms for the other enzymes used, except for Bgl II. In conclusion, these data show that all hybridizing fragments are derived from the conopressin gene, and that there is no evidence for an additional oxytocin-related gene in the Lymnaea genome. 
Conopressin is involved in the control qf reproductive behavior
The conopressin gene is expressed in neurons in the anterior lobes of both cerebral ganglia (Fig. 4A,B) . These neurons were previously shown to project into the penis nerve to innervate the penis complex and the vas deferens A. Ter Maat, A. W. Pieneman, and Y.A. Van Duivenboden, unpublished data) . In accordance, conopressin immunopositive axon bundles were observed in the penis nerve and in the vas deferens (Fig. 4C,D) , suggesting a possible role for conopressin in the control of the activities of the male copulation structures. This was further supported by the isolation and structural identification of Lys-conopressin from the penis complex and the vas deferens together.
Conopressin potently induced muscle contractions in the vas deferens at nM concentrations.
The frequency of these contractions was dose dependent within a physiological range of conopressin concentrations, with an EC,, of 4.3 nM (Fig. 5A) . Thus, conopressin may be involved in the control of ejaculation of semen during intromission in Lymnaea, which nicely corresponds to the proposed role of oxytocin in the regulation of vas deferens activity and ejaculation of semen in mammals (Todd and Lightman, 1986; Murphy et al., 1987) . In addition to effects on peripheral tissue, conopressin also affects central neurons involved in the regulation of reproductive behavior. Effects of Lysvasopressin on identified molluscan neurons have been noticed before (Barker and Gainer, 1974) . In the present study, we observed that anti-neurophysin-positive axons occur in close proximity of the axons of the CDC (Fig. 4E,F) , suggesting conopressinergic innervation of the CDC system. The CDCs are neuroendocrine cells that release egg-laying peptides and control egg mass production and associated female reproductive behavior (Geraerts et al., 1991) . Conopressin hyperpolarizes the CDC membrane potential and terminates an electrically triggered CDC discharge (Fig. 6 ), suggesting that conopressin may be able to inhibit peptide release by the CDC system and can prevent egg laying. These actions are meaningful in the context of the simultaneous hermaphroditic mode of reproduction of the animal, which necessitates a temporal patterning of the otherwise conflicting mating and egg-laying behaviors.
The vasopressin and oxytocin gene ,fhmily: evolution of genes and ,functions Our results support the view that an oxytocin-like peptide or gene is absent in Lymnaea. First, using immunological methods and well-characterized antisera, only the vasopressin-related peptide Lys-conopressin, but no oxytocin-related peptide could be identified in the CNS. Second, no conopressin-related cDNAs or genes could be identified using low-stringent hybridization as well as PCR amplification of oxytocin-like sequences. Third, the function of conopressin, i.e., control of reproductive behavior, is similar to that of oxytocin in mammals, suggesting that conopressin might represent an ancestral peptide of the vasopressin/ oxytocin superfamily, endowed with structural characteristics of vasopressin and functional characteristics of oxytocin. Therefore, we hypothesize that according to the current model the gene duplication that led to a vasopressinloxytocin two-gene family occurred early during vertebrate evolution, and that in invertebrates, only one gene is present.
Thus, the presence in invertebrates of both vasopressin-and
The Journal of Neuroscience, September 1995, 15(9) An afterdischarge was evoked by electrical stimulation of the CDC and Lys-conopressin (IO-" M) was applied at 2.5 min after the onset of the discharge (arrow). Conopressin rapidly hyperpolarized the CDC membrane potential and reduced the firing frequency. As a result of the hyperpolarization, the spike amplitude increased. The spiking activity from 20 set before until -5 min after application of conopressin is shown. B, Frequency plots of a control CDC dicharge (black clots) and a CDC discharge in the presence of conopressin (open dots). The control discharges lasted for 48 min, whereas the discharges in the presence of conopressin lasted for 13 min (single representative of four independent experiments).
oxytocin-like peptides (i.e., peptides with a basic and peptides with an aliphatic amino acid residue at position 8, respectively) results from the occasional mutation of a single gene rather than from gene duplication, and the mutation of residue 8 from a basic to an aliphatic residue may therefore be neutral with respect to peptide-receptor interactions and peptide functions in invertebrates. To test this, we synthesized [Ile8]-conopressin (i.e., Lys-conopressin with an isoleucine residue instead of a lysine residue at position S), and compared its myoactive effect with that of Lys-conopressin.
Isoleucine was substituted because oxytocin-related cephalotocin from Octopus, which is the closest related species to Lymnaea in which such a peptide has been identified, contains isoleucine at position 8. Both peptides have similar potencies on the Lymnaea vas deferens (Fig. 5A) and interact with the same receptor, since desensitization of the receptor by Lys-conopressin resulted in a desensitized response to [Ilex]-conopressin, but not to an unrelated -FF-amide peptide that also acts as an excitatory transmitter on the vas deferens (Li et al., 1995; Fig. 5B) . Thus, the amino acid change that distinguishes vasopressin from oxytocin in mammals, is functionally neutral in Lymnuea. This may explain why mutation of residue 8 from a basic to an aliphatic residue occurred independently in the evolution of the various invertebrate phyla, without altering the functional properties of the peptide. In vertebrates, on the other hand, duplication of the gene followed by mutation of residue 8 in one of the genes, resulted in separate evolutionary lineages in which different receptors co-evolved with each peptide, yielding functionally distinct peptide-receptor combinations.
